ORG Wealth Partners
MPLT icon

ORG Wealth Partners’s MapLight Therapeutics MPLT Stock Holding History

ORG Wealth Partners’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$81 Buy
+8
New +$150 ﹤0.01% 2475

Other funds holding MPLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

ORG Wealth Partners's MPLT Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in MapLight Therapeutics (MPLT) in Q3 2026: 8 shares worth $81. The stake represents ﹤0.01% of the portfolio and ranks #2475 among its holdings.

33 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

  • ORG Wealth Partners held 8 shares of MapLight Therapeutics worth $81 as of Q3 2026.
  • MapLight Therapeutics was a new ORG Wealth Partners position in Q3 2026.
  • MapLight Therapeutics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2475 holding.
  • 33 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.